Research Papers

25 of 1710 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabe…
Garofolo M; Lucchesi D; Giambalvo M; Aragona M; Bertolotto A; Campi F; Bianchi C; Francesconi P; Marchetti P; Del Prato S; Penno G.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Intensive lifestyle intervention in type 2 diabetes and risk of incident coronary artery disease for the common haptogl…
Warren RA; Bancks MP; Carew AS; Levy AP; Sapp J; Bahnson J; Lewis CE; Rimm EB; Espeland MA; Cahill LE.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Insulin resistance and coronary inflammation in patients with coronary artery disease: a cross-sectional study.
Yang T; Li G; Wang C; Xu G; Li Q; Yang Y; Zhu L; Chen L; Li X; Yang H.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Distribution and prognostic value of high-sensitivity cardiac troponin T and I across glycemic status: a population-bas…
Zhang J; Li X; Zhang S; Wang Z; Tian R; Xu F; Chen Y; Li C.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Link between triglyceride-glucose-body mass index and future stroke risk in middle-aged and elderly chinese: a nationwi…
Shao Y; Hu H; Li Q; Cao C; Liu D; Han Y.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Associations of the triglyceride-glucose index and atherogenic index of plasma with the severity of new-onset coronary …
Wu X; Qiu W; Yang H; Chen YJ; Liu J; Zhao G.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic …
Hu X; Feng D; Zhang Y; Wang C; Chen Y; Niu G; Zhou Z; Zhao Z; Zhang H; Wang M; Wu Y.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The effectiveness of sodium-glucose co-transporter 2 inhibitors on cardiorenal outcomes: an updated systematic review a…
Ali MU; Mancini GBJ; Fitzpatrick-Lewis D; Connelly KA; O'Meara E; Zieroth S; Sherifali D.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
DNA methylation risk score for type 2 diabetes is associated with gestational diabetes.
Linares-Pineda TM; Fragoso-Bargas N; Picón MJ; Molina-Vega M; Jenum AK; Sletner L; Lee-Ødegård S; Opsahl JO; Moen GH; Qvigstad E; Prasad RB; Birkeland KI; Morcillo S; Sommer C.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved eje…
Mohammed AQ; Luo Y; Wang K; Su Y; Liu L; Yin G; Zhang W; Alifu JJ; Mareai RM; Mohammed AA; Xu Y; Abdu FA; Che W.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition.
Bielka W; Przezak A; Molęda P; Pius-Sadowska E; Machaliński B.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Circulating exosomal mir-16-2-3p is associated with coronary microvascular dysfunction in diabetes through regulating t…
Liu Y; Zhong C; Chen S; Xue Y; Wei Z; Dong L; Kang L.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, a…
Lv Y; Li K; Wang S; Wang X; Yue G; Zhang Y; Lv X; Zhao P; Wang S; Zhang Q; Li Q; Zhu J; Li J; Peng P; Li Y; Luo J; Zhang X; Yang J; Zhang B; Wang X; Zhang M; Shen C; Wang X; Wang M; Ye Z; Cui Y.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode.
Verhulst CEM; van Heck JIP; Fabricius TW; Stienstra R; Teerenstra S; McCrimmon RJ; Tack CJ; Pedersen-Bjergaard U; de Galan BE; Hypo-RESOLVE consortium.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Revisiting an old relationship: the causal associations of the ApoB/ApoA1 ratio with cardiometabolic diseases and relat…
Fu C; Liu D; Liu Q; Wang X; Ma X; Pan H; Feng S; Sun Z; Qiao W; Yang M; Gao S; Ding H; Huang X; Hou J.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The impact of type 2 diabetes mellitus on the clinical profile, myocardial fibrosis, and prognosis in non-ischemic dila…
Li Y; Xian H; Xu Y; Li W; Guo J; Wan K; Wang J; Xu Z; Zhang Q; Han Y; Sun J; Chen Y.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complicati…
Gamez M; Elhegni HE; Fawaz S; Ho KH; Campbell NW; Copland DA; Onions KL; Butler MJ; Wasson EJ; Crompton M; Ramnath RD; Qiu Y; Yamaguchi Y; Arkill KP; Bates DO; Turnbull JE; Zubkova OV; Welsh GI; Atan D; Satchell SC; Foster RR.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial.
Januzzi JL; Del Prato S; Rosenstock J; Butler J; Ezekowitz J; Ibrahim NE; Lam CSP; Marwick T; Wilson Tang WH; Liu Y; Mohebi R; Urbinati A; Zannad F; Perfetti R.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Independent association of thigh muscle fat density with vascular events in Korean adults.
Choe HJ; Chang W; Blüher M; Heymsfield SB; Lim S.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Prognostic implications of systemic immune-inflammation index in myocardial infarction patients with and without diabet…
Luo J; Qin X; Zhang X; Zhang Y; Yuan F; Shi W; Liu B; Wei Y; NOAFCAMI-SH Registry Investigators.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage prog…
Piarulli F; Banfi C; Ragazzi E; Gianazza E; Munno M; Carollo M; Traldi P; Lapolla A; Sartore G.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Circulating palmitoyl sphingomyelin levels predict the 10-year increased risk of cardiovascular disease death in Chines…
Qian X; Jia H; Wang J; He S; Yu M; Feng X; Gong Q; An Y; Wang X; Shi N; Li H; Zou Z; Li G; Chen Y.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancest…
Zhao Y; Quan E; Zeng T; Huang Z; Luo Y; Peng L; Li S; Liu J; Chong Y; Cao H.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Correlation between triglyceride glucose index and collateral circulation formation in patients with chronic total occl…
Zhu J; Niu M; Wang C; Liang Y; Guo R; He F.
Cardiovasc Diabetol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Rena…
Vitale M; Orsi E; Solini A; Garofolo M; Resi V; Bonora E; Fondelli C; Trevisan R; Vedovato M; Penno G; Pugliese G.
Cardiovasc Diabetol (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared